Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 109 entries
Sorted by: Best Match Show Resources per page
Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent .

International journal of microbiology

Nowak A, Hedenstierna M, Ursing J, Lidman C, Nowak P.
PMID: 31354831
Int J Microbiol. 2019 Jul 01;2019:7395127. doi: 10.1155/2019/7395127. eCollection 2019.

BACKGROUND: Patients with recurrent METHODS: Medical records of all patients with recurrent CDI treated with FMT during the period 2013-2017 were reviewed. We evaluated cure of CDI-related diarrhea without relapse 10 weeks after FMT.RESULTS: 47 patients were included. One...

Cite
Nowak A, Hedenstierna M, Ursing J, et al. Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent . Int J Microbiol. 2019;2019:7395127doi: 10.1155/2019/7395127.
Nowak, A., Hedenstierna, M., Ursing, J., Lidman, C., & Nowak, P. (2019). Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent . International journal of microbiology, 20197395127. https://doi.org/10.1155/2019/7395127
Nowak, Alexandra, et al. "Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent ." International journal of microbiology vol. 2019 (2019): 7395127. doi: https://doi.org/10.1155/2019/7395127
Nowak A, Hedenstierna M, Ursing J, Lidman C, Nowak P. Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent . Int J Microbiol. 2019 Jul 01;2019:7395127. doi: 10.1155/2019/7395127. eCollection 2019. PMID: 31354831; PMCID: PMC6636641.
Copy Download .nbib Format: NLM
Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Physical review letters

Abbott TMC, Alarcon A, Allam S, Andersen P, Andrade-Oliveira F, Annis J, Asorey J, Avila S, Bacon D, Banik N, Bassett BA, Baxter E, Bechtol K, Becker MR, Bernstein GM, Bertin E, Blazek J, Bridle SL, Brooks D, Brout D, Burke DL, Calcino J, Camacho H, Campos A, Carnero Rosell A, Carollo D, Carrasco Kind M, Carretero J, Castander FJ, Cawthon R, Challis P, Chan KC, Chang C, Childress M, Crocce M, Cunha CE, D'Andrea CB, da Costa LN, Davis C, Davis TM, De Vicente J, DePoy DL, DeRose J, Desai S, Diehl HT, Dietrich JP, Dodelson S, Doel P, Drlica-Wagner A, Eifler TF, Elvin-Poole J, Estrada J, Evrard AE, Fernandez E, Flaugher B, Foley RJ, Fosalba P, Frieman J, Galbany L, García-Bellido J, Gatti M, Gaztanaga E, Gerdes DW, Giannantonio T, Glazebrook K, Goldstein DA, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hartley WG, Hinton SR, Hollowood DL, Honscheid K, Hoormann JK, Hoyle B, Huterer D, Jain B, James DJ, Jarvis M, Jeltema T, Kasai E, Kent S, Kessler R, Kim AG, Kokron N, Krause E, Kron R, Kuehn K, Kuropatkin N, Lahav O, Lasker J, Lemos P, Lewis GF, Li TS, Lidman C, Lima M, Lin H, Macaulay E, MacCrann N, Maia MAG, March M, Marriner J, Marshall JL, Martini P, McMahon RG, Melchior P, Menanteau F, Miquel R, Mohr JJ, Morganson E, Muir J, Möller A, Neilsen E, Nichol RC, Nord B, Ogando RLC, Palmese A, Pan YC, Peiris HV, Percival WJ, Plazas AA, Porredon A, Prat J, Romer AK, Roodman A, Rosenfeld R, Ross AJ, Rykoff ES, Samuroff S, Sánchez C, Sanchez E, Scarpine V, Schindler R, Schubnell M, Scolnic D, Secco LF, Serrano S, Sevilla-Noarbe I, Sharp R, Sheldon E, Smith M, Soares-Santos M, Sobreira F, Sommer NE, Swann E, Swanson MEC, Tarle G, Thomas D, Thomas RC, Troxel MA, Tucker BE, Uddin SA, Vielzeuf P, Walker AR, Wang M, Weaverdyck N, Wechsler RH, Weller J, Yanny B, Zhang B, Zhang Y, Zuntz J.
PMID: 31107093
Phys Rev Lett. 2019 May 03;122(17):171301. doi: 10.1103/PhysRevLett.122.171301.

The combination of multiple observational probes has long been advocated as a powerful technique to constrain cosmological parameters, in particular dark energy. The Dark Energy Survey has measured 207 spectroscopically confirmed type Ia supernova light curves, the baryon acoustic...

Cite
Abbott TMC, Alarcon A, Allam S, et al. Cosmological Constraints from Multiple Probes in the Dark Energy Survey. Phys Rev Lett. 2019;122(17):171301doi: 10.1103/PhysRevLett.122.171301.
Abbott, T. M. C., Alarcon, A., Allam, S., Andersen, P., Andrade-Oliveira, F., Annis, J., Asorey, J., Avila, S., Bacon, D., Banik, N., Bassett, B. A., Baxter, E., Bechtol, K., Becker, M. R., Bernstein, G. M., Bertin, E., Blazek, J., Bridle, S. L., Brooks, D., Brout, D., Burke, D. L., Calcino, J., Camacho, H., Campos, A., Carnero Rosell, A., Carollo, D., Carrasco Kind, M., Carretero, J., Castander, F. J., Cawthon, R., Challis, P., Chan, K. C., Chang, C., Childress, M., Crocce, M., Cunha, C. E., D'Andrea, C. B., da Costa, L. N., Davis, C., Davis, T. M., De Vicente, J., DePoy, D. L., DeRose, J., Desai, S., Diehl, H. T., Dietrich, J. P., Dodelson, S., Doel, P., Drlica-Wagner, A., Eifler, T. F., Elvin-Poole, J., Estrada, J., Evrard, A. E., Fernandez, E., Flaugher, B., Foley, R. J., Fosalba, P., Frieman, J., Galbany, L., García-Bellido, J., Gatti, M., Gaztanaga, E., Gerdes, D. W., Giannantonio, T., Glazebrook, K., Goldstein, D. A., Gruen, D., Gruendl, R. A., Gschwend, J., Gutierrez, G., Hartley, W. G., Hinton, S. R., Hollowood, D. L., Honscheid, K., Hoormann, J. K., Hoyle, B., Huterer, D., Jain, B., James, D. J., Jarvis, M., Jeltema, T., Kasai, E., Kent, S., Kessler, R., Kim, A. G., Kokron, N., Krause, E., Kron, R., Kuehn, K., Kuropatkin, N., Lahav, O., Lasker, J., Lemos, P., Lewis, G. F., Li, T. S., Lidman, C., Lima, M., Lin, H., Macaulay, E., MacCrann, N., Maia, M. A. G., March, M., Marriner, J., Marshall, J. L., Martini, P., McMahon, R. G., Melchior, P., Menanteau, F., Miquel, R., Mohr, J. J., Morganson, E., Muir, J., Möller, A., Neilsen, E., Nichol, R. C., Nord, B., Ogando, R. L. C., Palmese, A., Pan, Y. C., Peiris, H. V., Percival, W. J., Plazas, A. A., Porredon, A., Prat, J., Romer, A. K., Roodman, A., Rosenfeld, R., Ross, A. J., Rykoff, E. S., Samuroff, S., Sánchez, C., Sanchez, E., Scarpine, V., Schindler, R., Schubnell, M., Scolnic, D., Secco, L. F., Serrano, S., Sevilla-Noarbe, I., Sharp, R., Sheldon, E., Smith, M., Soares-Santos, M., Sobreira, F., Sommer, N. E., Swann, E., Swanson, M. E. C., Tarle, G., Thomas, D., Thomas, R. C., Troxel, M. A., Tucker, B. E., Uddin, S. A., Vielzeuf, P., Walker, A. R., Wang, M., Weaverdyck, N., Wechsler, R. H., Weller, J., Yanny, B., Zhang, B., Zhang, Y., Zuntz, J. (2019). Cosmological Constraints from Multiple Probes in the Dark Energy Survey. Physical review letters, 122(17), 171301. https://doi.org/10.1103/PhysRevLett.122.171301
Abbott, T M C, et al. "Cosmological Constraints from Multiple Probes in the Dark Energy Survey." Physical review letters vol. 122,17 (2019): 171301. doi: https://doi.org/10.1103/PhysRevLett.122.171301
Abbott TMC, Alarcon A, Allam S, Andersen P, Andrade-Oliveira F, Annis J, Asorey J, Avila S, Bacon D, Banik N, Bassett BA, Baxter E, Bechtol K, Becker MR, Bernstein GM, Bertin E, Blazek J, Bridle SL, Brooks D, Brout D, Burke DL, Calcino J, Camacho H, Campos A, Carnero Rosell A, Carollo D, Carrasco Kind M, Carretero J, Castander FJ, Cawthon R, Challis P, Chan KC, Chang C, Childress M, Crocce M, Cunha CE, D'Andrea CB, da Costa LN, Davis C, Davis TM, De Vicente J, DePoy DL, DeRose J, Desai S, Diehl HT, Dietrich JP, Dodelson S, Doel P, Drlica-Wagner A, Eifler TF, Elvin-Poole J, Estrada J, Evrard AE, Fernandez E, Flaugher B, Foley RJ, Fosalba P, Frieman J, Galbany L, García-Bellido J, Gatti M, Gaztanaga E, Gerdes DW, Giannantonio T, Glazebrook K, Goldstein DA, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hartley WG, Hinton SR, Hollowood DL, Honscheid K, Hoormann JK, Hoyle B, Huterer D, Jain B, James DJ, Jarvis M, Jeltema T, Kasai E, Kent S, Kessler R, Kim AG, Kokron N, Krause E, Kron R, Kuehn K, Kuropatkin N, Lahav O, Lasker J, Lemos P, Lewis GF, Li TS, Lidman C, Lima M, Lin H, Macaulay E, MacCrann N, Maia MAG, March M, Marriner J, Marshall JL, Martini P, McMahon RG, Melchior P, Menanteau F, Miquel R, Mohr JJ, Morganson E, Muir J, Möller A, Neilsen E, Nichol RC, Nord B, Ogando RLC, Palmese A, Pan YC, Peiris HV, Percival WJ, Plazas AA, Porredon A, Prat J, Romer AK, Roodman A, Rosenfeld R, Ross AJ, Rykoff ES, Samuroff S, Sánchez C, Sanchez E, Scarpine V, Schindler R, Schubnell M, Scolnic D, Secco LF, Serrano S, Sevilla-Noarbe I, Sharp R, Sheldon E, Smith M, Soares-Santos M, Sobreira F, Sommer NE, Swann E, Swanson MEC, Tarle G, Thomas D, Thomas RC, Troxel MA, Tucker BE, Uddin SA, Vielzeuf P, Walker AR, Wang M, Weaverdyck N, Wechsler RH, Weller J, Yanny B, Zhang B, Zhang Y, Zuntz J. Cosmological Constraints from Multiple Probes in the Dark Energy Survey. Phys Rev Lett. 2019 May 03;122(17):171301. doi: 10.1103/PhysRevLett.122.171301. PMID: 31107093.
Copy Download .nbib Format: NLM
Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Shoaib A, Spratt JC, Curzen N, Wilson S, Rashid M, Ahmad F, Ludman P, Kinnaird T, Mamas MA.
PMID: 34797596
Catheter Cardiovasc Interv. 2021 Nov 19; doi: 10.1002/ccd.30015. Epub 2021 Nov 19.

BACKGROUND: Long lesions are known to have worse outcomes following percutaneous coronary intervention (PCI), but there are limited data assessing the association between lesion length and clinical outcomes in PCI procedures undertaken in chronic total occlusions (CTO).METHODS AND RESULTS:...

Cite
Shoaib A, Spratt JC, Curzen N, et al. Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length. Catheter Cardiovasc Interv. 2021;doi: 10.1002/ccd.30015.
Shoaib, A., Spratt, J. C., Curzen, N., Wilson, S., Rashid, M., Ahmad, F., Ludman, P., Kinnaird, T., Mamas, M. A. (2021). Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, . https://doi.org/10.1002/ccd.30015
Shoaib, Ahmad, et al. "Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. (2021). doi: https://doi.org/10.1002/ccd.30015
Shoaib A, Spratt JC, Curzen N, Wilson S, Rashid M, Ahmad F, Ludman P, Kinnaird T, Mamas MA. Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length. Catheter Cardiovasc Interv. 2021 Nov 19; doi: 10.1002/ccd.30015. Epub 2021 Nov 19. PMID: 34797596.
Copy Download .nbib Format: NLM
The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions.

Acta biochimica Polonica

Permana S, Lukman H, Norahmawati E, Eka Puspita O, Faisal Moh Al Zein D, Kawamoto Y, Tri Endharti A.
PMID: 34264566
Acta Biochim Pol. 2021 Jul 15; doi: 10.18388/abp.2020_5563. Epub 2021 Jul 15.

The aim of this study is to investigate the combination treatments of paclitaxel and chitosan-Dendrophthoe pentandra leaves extract nanoparticles (NPDP) on MCF-7 breast cancer cells. Chitosan-NPDP nanoparticles were characterized by Fourier-transform infrared (FTIR), scanning electron microscopy (SEM), and assessed...

Cite
Permana S, Lukman H, Norahmawati E, et al. The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions. Acta Biochim Pol. 2021;doi: 10.18388/abp.2020_5563.
Permana, S., Lukman, H., Norahmawati, E., Eka Puspita, O., Faisal Moh Al Zein, D., Kawamoto, Y., & Tri Endharti, A. (2021). The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions. Acta biochimica Polonica, . https://doi.org/10.18388/abp.2020_5563
Permana, Sofy, et al. "The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions." Acta biochimica Polonica vol. (2021). doi: https://doi.org/10.18388/abp.2020_5563
Permana S, Lukman H, Norahmawati E, Eka Puspita O, Faisal Moh Al Zein D, Kawamoto Y, Tri Endharti A. The combination therapy of targeting both paclitaxel and Dendrophthoe pentandra leaves extract nanoparticles for improvement breast cancer treatment efficacy by reducing TUBB3 and MAP4 expressions. Acta Biochim Pol. 2021 Jul 15; doi: 10.18388/abp.2020_5563. Epub 2021 Jul 15. PMID: 34264566.
Copy Download .nbib Format: NLM
Microvalve Bioprinting of MSC-Chondrocyte Co-Cultures.

Cells

Dudman J, Ferreira AM, Gentile P, Wang X, Dalgarno K.
PMID: 34943837
Cells. 2021 Nov 27;10(12). doi: 10.3390/cells10123329.

Recent improvements within the fields of high-throughput screening and 3D tissue culture have provided the possibility of developing in vitro micro-tissue models that can be used to study diseases and screen potential new therapies. This paper reports a proof-of-concept...

Cite
Dudman J, Ferreira AM, Gentile P, et al. Microvalve Bioprinting of MSC-Chondrocyte Co-Cultures. Cells. 2021;10(12)doi: 10.3390/cells10123329.
Dudman, J., Ferreira, A. M., Gentile, P., Wang, X., & Dalgarno, K. (2021). Microvalve Bioprinting of MSC-Chondrocyte Co-Cultures. Cells, 10(12), . https://doi.org/10.3390/cells10123329
Dudman, Joseph, et al. "Microvalve Bioprinting of MSC-Chondrocyte Co-Cultures." Cells vol. 10,12 (2021). doi: https://doi.org/10.3390/cells10123329
Dudman J, Ferreira AM, Gentile P, Wang X, Dalgarno K. Microvalve Bioprinting of MSC-Chondrocyte Co-Cultures. Cells. 2021 Nov 27;10(12). doi: 10.3390/cells10123329. PMID: 34943837.
Copy Download .nbib Format: NLM
Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Cockburn J, Kemp T, Ludman P, Kinnaird T, Johnson T, Curzen N, Robinson D, Mamas M, de Belder A, Hildick-Smith D.
PMID: 33283484
Catheter Cardiovasc Interv. 2021 Dec 01;98(7):1300-1307. doi: 10.1002/ccd.29406. Epub 2020 Dec 06.

OBJECTIVE: Octogenarians are a high-risk group presenting for percutaneous coronary intervention (PCI). We aimed to create a 30-day mortality risk model for octogenarians presenting with both acute coronary syndrome (ACS) and chronic stable angina (CSA), using comprehensive mandatory UK...

Cite
Cockburn J, Kemp T, Ludman P, et al. Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheter Cardiovasc Interv. 2020;98(7):1300-1307doi: 10.1002/ccd.29406.
Cockburn, J., Kemp, T., Ludman, P., Kinnaird, T., Johnson, T., Curzen, N., Robinson, D., Mamas, M., de Belder, A., Hildick-Smith, D. (2021). Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 98(7), 1300-1307. https://doi.org/10.1002/ccd.29406
Cockburn, James, et al. "Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 98,7 (2021): 1300-1307. doi: https://doi.org/10.1002/ccd.29406
Cockburn J, Kemp T, Ludman P, Kinnaird T, Johnson T, Curzen N, Robinson D, Mamas M, de Belder A, Hildick-Smith D. Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly. Catheter Cardiovasc Interv. 2021 Dec 01;98(7):1300-1307. doi: 10.1002/ccd.29406. Epub 2020 Dec 06. PMID: 33283484.
Copy Download .nbib Format: NLM
The effectiveness of passive ultrasonic irrigation and the easy-clean instrument for removing remnants of filling material.

Journal of conservative dentistry : JCD

de Souza DS, S Silva AS, Ormiga F, Lopes RT, Gusman H.
PMID: 34475681
J Conserv Dent. 2021 Jan-Feb;24(1):57-62. doi: 10.4103/JCD.JCD_590_20. Epub 2021 Jul 05.

OBJECTIVE: This study aimed to evaluate the efficacy of passive ultrasonic irrigation (PUI) and the easy clean instrument by micro-computed tomography (CT) for removing remnant filling materials during endodontic retreatment.MATERIALS AND METHODS: Forty mesial roots of mandibular molars were...

Cite
de Souza DS, S Silva AS, Ormiga F, et al. The effectiveness of passive ultrasonic irrigation and the easy-clean instrument for removing remnants of filling material. J Conserv Dent. 2021;24(1):57-62doi: 10.4103/JCD.JCD_590_20.
de Souza, D. S., S Silva, A. S., Ormiga, F., Lopes, R. T., & Gusman, H. (2021). The effectiveness of passive ultrasonic irrigation and the easy-clean instrument for removing remnants of filling material. Journal of conservative dentistry : JCD, 24(1), 57-62. https://doi.org/10.4103/JCD.JCD_590_20
de Souza, Danielle Santos, et al. "The effectiveness of passive ultrasonic irrigation and the easy-clean instrument for removing remnants of filling material." Journal of conservative dentistry : JCD vol. 24,1 (2021): 57-62. doi: https://doi.org/10.4103/JCD.JCD_590_20
de Souza DS, S Silva AS, Ormiga F, Lopes RT, Gusman H. The effectiveness of passive ultrasonic irrigation and the easy-clean instrument for removing remnants of filling material. J Conserv Dent. 2021 Jan-Feb;24(1):57-62. doi: 10.4103/JCD.JCD_590_20. Epub 2021 Jul 05. PMID: 34475681; PMCID: PMC8378483.
Copy Download .nbib Format: NLM
Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems.

Virology

Auguste AJ, Langsjoen RM, Porier DL, Erasmus JH, Bergren NA, Bolling BG, Luo H, Singh A, Guzman H, Popov VL, Travassos da Rosa APA, Wang T, Kang L, Allen IC, Carrington CVF, Tesh RB, Weaver SC.
PMID: 34256244
Virology. 2021 Oct;562:50-62. doi: 10.1016/j.virol.2021.07.004. Epub 2021 Jul 08.

We describe the isolation and characterization of a novel insect-specific flavivirus (ISFV), tentatively named Aripo virus (ARPV), that was isolated from Psorophora albipes mosquitoes collected in Trinidad. The ARPV genome was determined and phylogenetic analyses showed that it is...

Cite
Auguste AJ, Langsjoen RM, Porier DL, et al. Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems. Virology. 2021;562:50-62doi: 10.1016/j.virol.2021.07.004.
Auguste, A. J., Langsjoen, R. M., Porier, D. L., Erasmus, J. H., Bergren, N. A., Bolling, B. G., Luo, H., Singh, A., Guzman, H., Popov, V. L., Travassos da Rosa, A. P. A., Wang, T., Kang, L., Allen, I. C., Carrington, C. V. F., Tesh, R. B., & Weaver, S. C. (2021). Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems. Virology, 56250-62. https://doi.org/10.1016/j.virol.2021.07.004
Auguste, Albert J, et al. "Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems." Virology vol. 562 (2021): 50-62. doi: https://doi.org/10.1016/j.virol.2021.07.004
Auguste AJ, Langsjoen RM, Porier DL, Erasmus JH, Bergren NA, Bolling BG, Luo H, Singh A, Guzman H, Popov VL, Travassos da Rosa APA, Wang T, Kang L, Allen IC, Carrington CVF, Tesh RB, Weaver SC. Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems. Virology. 2021 Oct;562:50-62. doi: 10.1016/j.virol.2021.07.004. Epub 2021 Jul 08. PMID: 34256244; PMCID: PMC8419152.
Copy Download .nbib Format: NLM
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes.

European heart journal. Quality of care & clinical outcomes

Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, Ludman P, Maggioni AP, Price S, Weston C, Casadei B, Gale CP.
PMID: 32845314
Eur Heart J Qual Care Clin Outcomes. 2020 Aug 26; doi: 10.1093/ehjqcco/qcaa069. Epub 2020 Aug 26.

AIMS: It is increasingly recognised that tools are required for assessing and benchmarking quality of care in order to improve it. The European Society of Cardiology (ESC) is developing a suite of quality indicators (QIs) to evaluate cardiovascular care...

Cite
Aktaa S, Batra G, Wallentin L, et al. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes. 2020;doi: 10.1093/ehjqcco/qcaa069.
Aktaa, S., Batra, G., Wallentin, L., Baigent, C., Erlinge, D., James, S., Ludman, P., Maggioni, A. P., Price, S., Weston, C., Casadei, B., & Gale, C. P. (2020). European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. European heart journal. Quality of care & clinical outcomes, . https://doi.org/10.1093/ehjqcco/qcaa069
Aktaa, Suleman, et al. "European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes." European heart journal. Quality of care & clinical outcomes vol. (2020). doi: https://doi.org/10.1093/ehjqcco/qcaa069
Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, Ludman P, Maggioni AP, Price S, Weston C, Casadei B, Gale CP. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes. 2020 Aug 26; doi: 10.1093/ehjqcco/qcaa069. Epub 2020 Aug 26. PMID: 32845314.
Copy Download .nbib Format: NLM
Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature.

PloS one

Reed MS, Curtis T, Gosal A, Kendall H, Andersen SP, Ziv G, Attlee A, Fitton RG, Hay M, Gibson AC, Hume AC, Hill D, Mansfield JL, Martino S, Olesen AS, Prior S, Rodgers C, Rudman H, Tanneberger F.
PMID: 35020743
PLoS One. 2022 Jan 12;17(1):e0258334. doi: 10.1371/journal.pone.0258334. eCollection 2022.

Ecosystem markets are proliferating around the world in response to increasing demand for climate change mitigation and provision of other public goods. However, this may lead to perverse outcomes, for example where public funding crowds out private investment or...

Cite
Reed MS, Curtis T, Gosal A, et al. Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature. PLoS One. 2022;17(1):e0258334doi: 10.1371/journal.pone.0258334.
Reed, M. S., Curtis, T., Gosal, A., Kendall, H., Andersen, S. P., Ziv, G., Attlee, A., Fitton, R. G., Hay, M., Gibson, A. C., Hume, A. C., Hill, D., Mansfield, J. L., Martino, S., Olesen, A. S., Prior, S., Rodgers, C., Rudman, H., & Tanneberger, F. (2022). Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature. PloS one, 17(1), e0258334. https://doi.org/10.1371/journal.pone.0258334
Reed, Mark S, et al. "Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature." PloS one vol. 17,1 (2022): e0258334. doi: https://doi.org/10.1371/journal.pone.0258334
Reed MS, Curtis T, Gosal A, Kendall H, Andersen SP, Ziv G, Attlee A, Fitton RG, Hay M, Gibson AC, Hume AC, Hill D, Mansfield JL, Martino S, Olesen AS, Prior S, Rodgers C, Rudman H, Tanneberger F. Integrating ecosystem markets to co-ordinate landscape-scale public benefits from nature. PLoS One. 2022 Jan 12;17(1):e0258334. doi: 10.1371/journal.pone.0258334. eCollection 2022. PMID: 35020743; PMCID: PMC8754326.
Copy Download .nbib Format: NLM
Predicting Chronic Wound Healing Time using Machine Learning to Support Real-Time Clinical Decisions.

Advances in wound care

Berezo ML, Budman J, Deutscher D, Thomas Hess C, Smith K, Hayes D.
PMID: 34465220
Adv Wound Care (New Rochelle). 2021 Sep 01; doi: 10.1089/wound.2021.0073. Epub 2021 Sep 01.

No abstract available.

Cite
Berezo ML, Budman J, Deutscher D, et al. Predicting Chronic Wound Healing Time using Machine Learning to Support Real-Time Clinical Decisions. Adv Wound Care (New Rochelle). 2021;doi: 10.1089/wound.2021.0073.
Berezo, M. L., Budman, J., Deutscher, D., Thomas Hess, C., Smith, K., & Hayes, D. (2021). Predicting Chronic Wound Healing Time using Machine Learning to Support Real-Time Clinical Decisions. Advances in wound care, . https://doi.org/10.1089/wound.2021.0073
Berezo, Matthew L, et al. "Predicting Chronic Wound Healing Time using Machine Learning to Support Real-Time Clinical Decisions." Advances in wound care vol. (2021). doi: https://doi.org/10.1089/wound.2021.0073
Berezo ML, Budman J, Deutscher D, Thomas Hess C, Smith K, Hayes D. Predicting Chronic Wound Healing Time using Machine Learning to Support Real-Time Clinical Decisions. Adv Wound Care (New Rochelle). 2021 Sep 01; doi: 10.1089/wound.2021.0073. Epub 2021 Sep 01. PMID: 34465220.
Copy Download .nbib Format: NLM
Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization.

ACS medicinal chemistry letters

Gutman H, Bazylevich A, Prasad C, Dorfman O, Hesin A, Marks V, Patsenker L, Gellerman G.
PMID: 34676042
ACS Med Chem Lett. 2021 Sep 07;12(10):1596-1604. doi: 10.1021/acsmedchemlett.1c00432. eCollection 2021 Oct 14.

We developed a highly potent anticancer agent, dolastatinol, which is a methylene hydroxyl derivative of dolastatin 10. Dolastatinol is a synthetic analog of dolastatin 10, synthesized by a solid-phase peptide Fmoc chemistry protocol on 2-chlorotrityl chloride resin utilizing a...

Cite
Gutman H, Bazylevich A, Prasad C, et al. Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization. ACS Med Chem Lett. 2021;12(10):1596-1604doi: 10.1021/acsmedchemlett.1c00432.
Gutman, H., Bazylevich, A., Prasad, C., Dorfman, O., Hesin, A., Marks, V., Patsenker, L., & Gellerman, G. (2021). Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization. ACS medicinal chemistry letters, 12(10), 1596-1604. https://doi.org/10.1021/acsmedchemlett.1c00432
Gutman, Hodaya, et al. "Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization." ACS medicinal chemistry letters vol. 12,10 (2021): 1596-1604. doi: https://doi.org/10.1021/acsmedchemlett.1c00432
Gutman H, Bazylevich A, Prasad C, Dorfman O, Hesin A, Marks V, Patsenker L, Gellerman G. Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization. ACS Med Chem Lett. 2021 Sep 07;12(10):1596-1604. doi: 10.1021/acsmedchemlett.1c00432. eCollection 2021 Oct 14. PMID: 34676042; PMCID: PMC8521654.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 109 entries